Traws Pharma Inc

Research Traws Pharma Inc (TRAW) on Bullrun: market cap USD 12.43M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerTRAW
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 12.43M
• Financial periodFY2025
• RevenueUSD 2.79M
• Revenue growth1134.5%
• Net incomeUSD 9.17M
• Free cash flow-USD 20.77M

Valuation Snapshot

latest market cap is USD 12.43M.

About Traws Pharma Inc

Traws Pharma, Inc., a clinical-stage biopharmaceutical company, develops small synthetic molecules for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and COVID-19 that are designed to address treatment resistance, such as TRX01 (Ratutrelvir), an inhibitor in development for the treatment of COVID-19; and Tivoxavir marboxil, an endonuclease inhibitor in development for the treatment of bird flu and seasonal influenza.

Frequently asked questions

What is Traws Pharma Inc's market cap?

Traws Pharma Inc's market capitalization is USD 12.43M.

What does Traws Pharma Inc do?

Traws Pharma, Inc., a clinical-stage biopharmaceutical company, develops small synthetic molecules for respiratory viral diseases and cancer.